Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

29.04.2024

4 BMC Neurol
3 Diabetes
9 Diabetes Res Clin Pract
3 Intern Med
3 J Autoimmun
3 J Clin Endocrinol Metab
1 J Immunol
1 J Neuroimmunol
3 J Neurol
1 J Pediatr Endocrinol Metab
2 Lancet
3 Mult Scler
6 Neurology



    BMC Neurol

  1. UZAWA A, Suzuki S, Kuwabara S, Akamine H, et al
    Taste disorders and alopecia in myasthenia gravis.
    BMC Neurol. 2024;24:139.
    >> Share

  2. ZHONG R, Chen X, Liao F, Lin Z, et al
    FLAMES overlaying anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review.
    BMC Neurol. 2024;24:140.
    >> Share

  3. SELLITTO G, Ruotolo I, Ianniello A, Felicetti F, et al
    Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS.
    BMC Neurol. 2024;24:138.
    >> Share

  4. HU S, Lin Z, Liu T, Huang S, et al
    Guillain-Barre syndrome following scrub typhus: a case report and literature review.
    BMC Neurol. 2024;24:137.
    >> Share


    Diabetes

  5. CALLEBAUT A, Guyer P, Derua R, Buitinga M, et al
    CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.
    Diabetes. 2024 Feb 22:db230588. doi: 10.2337/db23-0588.
    >> Share

  6. CALLEBAUT A, Guyer P, Baker RL, Gallegos JB, et al
    An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.
    Diabetes. 2024 Jan 31:db230622. doi: 10.2337/db23-0622.
    >> Share

  7. TANG Y, Ang L, Jaiswal M, Dillon BR, et al
    Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: findings from the PERL and ACCORD cohorts.
    Diabetes. 2023 Jul 19:db230247. doi: 10.2337/db23-0247.
    >> Share


    Diabetes Res Clin Pract

  8. TATULASHVILI S, Dreves B, Meyer L, Cosson E, et al
    Carbohydrate counting knowledge and ambulatory glucose profile in persons living with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;210:111592.
    >> Share

  9. CITRO F, Bianchi C, Aragona M, Belcari T, et al
    Accuracy of intermittently scanned continuous glucose monitoring during caesarean delivery in pregnant women with insulin-treated diabetes.
    Diabetes Res Clin Pract. 2024;210:111611.
    >> Share

  10. GUPTA A, Mukherjee S, Kumar Bhadada S, Ram S, et al
    Impact of short-term application of continuous glucose monitoring system(CGMS) on long-term glycemic profile in adolescents and adults with type 1 diabetes mellitus: An open-label randomized control cross over study.
    Diabetes Res Clin Pract. 2024;210:111610.
    >> Share

  11. RASBACH L, Purrington G, Adkins D, Benjamin R, et al
    Innovations: Using telemedicine to improve care of predominantly non-white youth with suboptimal insulin dependent diabetes control.
    Diabetes Res Clin Pract. 2024;210:111613.
    >> Share

  12. MARIGLIANO M, Lanzinger S, Zineb I, Barcala C, et al
    The role of sex on the prevalence of cardiovascular risk factors in children and adolescents with Type 1 diabetes: The SWEET international database.
    Diabetes Res Clin Pract. 2024;210:111616.
    >> Share

  13. MOTTL AK, Tryggestad JB, Isom S, Gubitosi-Klug RA, et al
    Major adverse events in youth-onset type 1 and type 2 diabetes: The SEARCH and TODAY studies.
    Diabetes Res Clin Pract. 2024;210:111606.
    >> Share

  14. CHERUBINI V, Fargalli A, Arnaldi C, Bassi M, et al
    Glucometrics and device satisfaction in children and adolescents with type 1 diabetes using different treatment modalities: A multicenter real-world observational study.
    Diabetes Res Clin Pract. 2024;210:111621.
    >> Share

  15. PARENT C, Lespagnol E, Berthoin S, Tagougui S, et al
    Continuous moderate and intermittent high-intensity exercise in youth with type 1 diabetes: Which protection for dysglycemia?
    Diabetes Res Clin Pract. 2024;210:111631.
    >> Share

  16. BERTHON W, McGurnaghan SJ, Blackbourn LAK, Mellor J, et al
    Ongoing burden and recent trends in severe hospitalised hypoglycaemia events in people with type 1 and type 2 diabetes in Scotland: A nationwide cohort study 2016-2022.
    Diabetes Res Clin Pract. 2024;210:111642.
    >> Share


    Intern Med

  17. SAITO S, Hontsu S, Hiraoka J, Yamanaka A, et al
    A Rare Case of Overlapping Durvalumab-induced Myositis, Takotsubo-like Morphological Changes Caused by Myocarditis, and Myasthenia Gravis.
    Intern Med. 2024 Apr 23. doi: 10.2169/internalmedicine.3028.
    >> Share

  18. NAKANOH H, Takeuchi H, Shiho M, Terajima Y, et al
    Successful treatment for life threatening recurrent non-traumatic rectus sheath hematoma in a case with microscopic polyangiitis with rapidly progressive glomerulonephritis.
    Intern Med. 2024 Apr 23. doi: 10.2169/internalmedicine.3239.
    >> Share

  19. TAJIRI K
    Immune Checkpoint Inhibitor Myotoxicities: An Autoimmune Perspective.
    Intern Med. 2024 Apr 23. doi: 10.2169/internalmedicine.3700.
    >> Share


    J Autoimmun

  20. DO JS, Arribas-Layton D, Juan J, Garcia I, et al
    The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation.
    J Autoimmun. 2024;146:103228.
    >> Share

  21. CHUANG HC, Lan KY, Hsu PM, Chen MH, et al
    UHRF1P contributes to IL-17A-mediated systemic lupus erythematosus via UHRF1-MAP4K3 axis.
    J Autoimmun. 2024;146:103221.
    >> Share

  22. ESEN I, Sandovici M, Heeringa P, Boots AMH, et al
    Impaired IL-6-induced JAK-STAT signaling in CD4(+) T cells associates with longer treatment duration in giant cell arteritis.
    J Autoimmun. 2024;146:103215.
    >> Share


    J Clin Endocrinol Metab

  23. TSAITLIN-MOR L, Cahen-Peretz A, Bentov Y, Ben-Shushan T, et al
    Long-Term Risk for Type 1 Diabetes and Obesity in Early Term Born Offspring: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2023 Dec 11:dgad715. doi: 10.1210.
    >> Share

  24. HOOPER AJ
    Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study".
    J Clin Endocrinol Metab. 2023 Dec 11:dgad719. doi: 10.1210.
    >> Share

  25. WU HX, Chu TY, Iqbal J, Jiang HL, et al
    Response to Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2023 Dec 9:dgad720. doi: 10.1210.
    >> Share


    J Immunol

  26. TAO Q, Chen Y, Liang Q, Shi J, et al
    Puerarin Alleviates Experimental Autoimmune Thyroiditis by Regulating Macrophages.
    J Immunol. 2024 Apr 26:ji2300779. doi: 10.4049/jimmunol.2300779.
    >> Share


    J Neuroimmunol

  27. LI V, Binder MD, Purcell AW, Kilpatrick TJ, et al
    Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis.
    J Neuroimmunol. 2024;390:578347.
    >> Share


    J Neurol

  28. ROSENSTEIN I, Nordin A, Sabir H, Malmestrom C, et al
    Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis.
    J Neurol. 2024 Apr 26. doi: 10.1007/s00415-024-12389.
    >> Share

  29. FONTE J, Stabile A, de Curtis M, Di Giacomo R, et al
    Seizures in autoimmune-associated epilepsy: a long-term video-EEG monitoring study.
    J Neurol. 2024 Apr 24. doi: 10.1007/s00415-024-12385.
    >> Share

  30. NAUTA IM, van Dam M, Bertens D, Kessels RPC, et al
    Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trial.
    J Neurol. 2024 Apr 23. doi: 10.1007/s00415-024-12327.
    >> Share


    J Pediatr Endocrinol Metab

  31. YAZKAN AKGUL G, Koprulu O
    Examination of quality of life and psychiatric symptoms in childhood Graves' disease.
    J Pediatr Endocrinol Metab. 2024 Apr 22. doi: 10.1515/jpem-2023-0550.
    >> Share


    Lancet

  32. KRICKAU T, Naumann-Bartsch N, Aigner M, Kharboutli S, et al
    CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis.
    Lancet. 2024 Apr 17:S0140-6736(24)00424-0. doi: 10.1016/S0140-6736(24)00424.
    >> Share

  33. HOI A, Igel T, Mok CC, Arnaud L, et al
    Systemic lupus erythematosus.
    Lancet. 2024 Apr 17:S0140-6736(24)00398-2. doi: 10.1016/S0140-6736(24)00398.
    >> Share


    Mult Scler

  34. MANUEL AM, Gottlieb A, Freeman L, Zhao Z, et al
    Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data.
    Mult Scler. 2024 Apr 25:13524585241240398. doi: 10.1177/13524585241240398.
    >> Share

  35. BIANCHI A, Cortese R, Prados F, Tur C, et al
    Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
    Mult Scler. 2024 Apr 22:13524585241240420. doi: 10.1177/13524585241240420.
    >> Share

  36. NOVAK F, Bajwa HM, Ostergaard K, Berg JM, et al
    Extended interval dosing with ocrelizumab in multiple sclerosis.
    Mult Scler. 2024 Apr 22:13524585241245296. doi: 10.1177/13524585241245296.
    >> Share


    Neurology

  37. VALKO Y, Wirth MA, Fierz FC, Schesny MK, et al
    Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
    Neurology. 2024;102:e209395.
    >> Share

  38. LIAO J, Lu Y, Lu Y, Huang Y, et al
    Cardiopulmonary Coupling Spectrogram as an Ambulatory Method for Assessing Sleep Disorders in Patients With Autoimmune Encephalitis.
    Neurology. 2024;102:e209302.
    >> Share

  39. MICHAELSON NM
    Right Brain: The Unraveling.
    Neurology. 2024;102:e209492.
    >> Share

  40. VYAS MV, Kapral MK, Alonzo R, Fang J, et al
    Proportion of Life Spent in Canada and the Incidence of Multiple Sclerosis in Permanent Immigrants.
    Neurology. 2024;102:e209350.
    >> Share

  41. SILBERMANN E, Spain RI
    Serum Neurofilament Light Chain for Multiple Sclerosis Relapses: Too Little Too Late?
    Neurology. 2024;102:e209456.
    >> Share

  42. FOX RJ, Cree BAC, de Seze J, Gold R, et al
    Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e209357.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016